These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 9008283)

  • 21. Expression of activation-related molecules on regional lymph node lymphocytes in human lung cancer.
    Takenoyama M; Yasumoto K; Harada M; Matsuzaki G; Ishida T; Sugimachi K; Nomoto K
    Immunobiology; 1996 Jul; 195(2):140-51. PubMed ID: 8877391
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Virus burden in long-term survivors of human immunodeficiency virus (HIV) infection is a determinant of anti-HIV CD8+ lymphocyte activity.
    Ferbas J; Kaplan AH; Hausner MA; Hultin LE; Matud JL; Liu Z; Panicali DL; Nerng-Ho H; Detels R; Giorgi JV
    J Infect Dis; 1995 Aug; 172(2):329-39. PubMed ID: 7622874
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Study of LDL and acetylated LDL endocytosis by mononuclear cells in HIV infection.
    Juompan L; Puel J; Fournié GJ; Benoist H
    Biochim Biophys Acta; 1995 Aug; 1272(1):21-8. PubMed ID: 7545009
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Indicators of T-cell activation: correlation between quantitative CD38 expression and soluble CD8 levels in asymptomatic HIV+ individuals and healthy controls.
    Lenkei R; Bratt G; Holmberg V; Muirhead K; Sandström E
    Cytometry; 1998 Oct; 33(2):115-22. PubMed ID: 9773871
    [TBL] [Abstract][Full Text] [Related]  

  • 25. During HIV infection, CD4+ CD38+ T-cells are the predominant circulating CD4+ subset whose HLA-DR positivity increases with disease progression and whose V beta repertoire is similar to that of CD4+ CD38- T-cells.
    Ramzaoui S; Jouen-Beades F; Gilbert D; Borsa-Lebas F; Michel Y; Humbert G; Tron F
    Clin Immunol Immunopathol; 1995 Oct; 77(1):33-41. PubMed ID: 7554481
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stimulated proliferative responses in vertically HIV-infected children on HAART correlate with clinical and immunological markers.
    Resino S; Abad ML; Navarro J; Bellón JM; Sánchez-Ramón S; Angeles Muñoz-Fernández M
    Clin Exp Immunol; 2003 Jan; 131(1):130-7. PubMed ID: 12519396
    [TBL] [Abstract][Full Text] [Related]  

  • 27. T cell responses to peptides covering the gag p24 region of HIV-1 occur in HIV-1 seronegative individuals.
    Vyakarnam A; Matear PM; Cranenburg C; Michie C; Beverley PC; Wahren B; Gill SK; Weller I
    Int Immunol; 1991 Oct; 3(10):939-47. PubMed ID: 1721834
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of human immunodeficiency virus antigens as stimulants for lymphocyte proliferation assays.
    Schmitz JL; Denny TN; Garcia A; Lathey JL;
    Clin Diagn Lab Immunol; 2002 May; 9(3):525-9. PubMed ID: 11986255
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Different meaning of CD38 molecule expression on CD4+ and CD8+ cells of children perinatally infected with human immunodeficiency virus type 1 infection surviving longer than five years.
    de Martino M; Rossi ME; Azzari C; Gelli MG; Galli L; Vierucci A
    Pediatr Res; 1998 Jun; 43(6):752-8. PubMed ID: 9621984
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preservation of lymphocyte immunophenotype and proliferative responses in cryopreserved peripheral blood mononuclear cells from human immunodeficiency virus type 1-infected donors: implications for multicenter clinical trials. The ACTG Immunology Advanced Technology Laboratories.
    Reimann KA; Chernoff M; Wilkening CL; Nickerson CE; Landay AL
    Clin Diagn Lab Immunol; 2000 May; 7(3):352-9. PubMed ID: 10799445
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation between the degree of immune activation, production of IL-2 and FOXP3 expression in CD4+CD25+ T regulatory cells in HIV-1 infected persons under HAART.
    Terzieva V; Popova D; Kicheva M; Todorova Y; Markova R; Martinova F; Elenkov I; Yankova M
    Int Immunopharmacol; 2009 Jul; 9(7-8):831-6. PubMed ID: 19303058
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation and cell cycle antigens in CD4+ and CD8+ T cells correlate with plasma human immunodeficiency virus (HIV-1) RNA level in HIV-1 infection.
    Orendi JM; Bloem AC; Borleffs JC; Wijnholds FJ; de Vos NM; Nottet HS; Visser MR; Snippe H; Verhoef J; Boucher CA
    J Infect Dis; 1998 Nov; 178(5):1279-87. PubMed ID: 9780247
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Infection of CD127+ (interleukin-7 receptor+) CD4+ cells and overexpression of CTLA-4 are linked to loss of antigen-specific CD4 T cells during primary human immunodeficiency virus type 1 infection.
    Zaunders JJ; Ip S; Munier ML; Kaufmann DE; Suzuki K; Brereton C; Sasson SC; Seddiki N; Koelsch K; Landay A; Grey P; Finlayson R; Kaldor J; Rosenberg ES; Walker BD; Fazekas de St Groth B; Cooper DA; Kelleher AD
    J Virol; 2006 Oct; 80(20):10162-72. PubMed ID: 17005693
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human immunodeficiency virus type 1 (HIV-1)-specific CD4+ T cells that proliferate in vitro detected in samples from most viremic subjects and inversely associated with plasma HIV-1 levels.
    Boritz E; Palmer BE; Wilson CC
    J Virol; 2004 Nov; 78(22):12638-46. PubMed ID: 15507650
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prospective analyses of HIV-1-specific proliferative responses, recall antigen proliferative responses, and clinical outcomes in an HIV-1-seropositive cohort.
    Ratto-Kim S; Garner RP; Kim JH; Jagodzinski LL; Michael NL; Paris R; Redfield RR; Birx DL
    J Infect Dis; 2004 Jun; 189(11):1988-95. PubMed ID: 15143464
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alterations in the immune response of human immunodeficiency virus (HIV)-infected subjects treated with an HIV-specific protease inhibitor, ritonavir.
    Kelleher AD; Carr A; Zaunders J; Cooper DA
    J Infect Dis; 1996 Feb; 173(2):321-9. PubMed ID: 8568292
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased expression of CD80 and CD86 in in vitro-infected CD3+ cells producing cytoplasmic HIV type 1 p24.
    Jason J; Inge KL
    AIDS Res Hum Retroviruses; 1999 Jan; 15(2):173-81. PubMed ID: 10029249
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes of blood CD16/CD56 (NK) and HLA-DR/CD3-positive lymphocyte amounts in HIV-infected children, as related to clinical progression and p24-antigen/p24-antibody presence.
    Voiculescu C; Avramescu C; Balasoiu M; Turculeanu A; Radu E
    FEMS Immunol Med Microbiol; 1994 Sep; 9(3):217-21. PubMed ID: 7529081
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HLA-DR-restricted peptides identified in the Nef protein can induce HIV type 1-specific IL-2/IFN-gamma-secreting CD4+ and CD4+ /CD8+ T cells in humans after lipopeptide vaccination.
    Gahery H; Figueiredo S; Texier C; Pouvelle-Moratille S; Ourth L; Igea C; Surenaud M; Guillet JG; Maillere B
    AIDS Res Hum Retroviruses; 2007 Mar; 23(3):427-37. PubMed ID: 17411376
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Binding of HIV-1 virions or gp120-anti-gp120 immune complexes to HIV-1-infected quiescent peripheral blood mononuclear cells reveals latent infection.
    Briant L; Coudronnière N; Robert-Hebmann V; Benkirane M; Devaux C
    J Immunol; 1996 May; 156(10):3994-4004. PubMed ID: 8621941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.